Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial

Authors

Weihang Bao (ORCID: https://orcid.org/0000-0001-6331-0805)
Kara W Chew (ORCID: https://orcid.org/0000-0003-4865-4348)
Jennifer Hammond (ORCID: https://orcid.org/0000-0003-0809-3953)
Wajeeha Ansari (ORCID: https://orcid.org/0000-0002-1910-5836)
James M. Rusnak
Heidi Leister‐Tebbe
Rienk Pypstra
Annie Gardner
Wayne Wisemandle
Paula Abreu (ORCID: https://orcid.org/0000-0003-4871-8532)
Magdalena Harrington (ORCID: https://orcid.org/0009-0006-5193-2678)
Jesus Abraham Simón Campos (ORCID: https://orcid.org/0000-0001-9630-7792)

Institutions

University of California, Los Angeles (US)
Pfizer (United States) (US)
Anahuac Mayab University (MX)
Kohler (United States) (US)

Publication Details

Journal: Clinical Infectious Diseases
Published: 2024-11-11
DOI: https://doi.org/10.1093/cid/ciae551
Citations: 10
Primary Topic: Thermal Regulation in Medicine
Type: article
Field-Weighted Citation Impact: 4.22

Funders

Pfizer

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial

Weihang Bao, Kara W Chew, Jennifer Hammond, Wajeeha Ansari et al.

Nov 11, 2024

10 citations

Clinical Infectious Diseases

Thermal Regulation in Medicine

4.22

article

Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial

Weihang Bao, Kara W Chew, Jennifer Hammond, Wajeeha Ansari, James M. Rusnak, Heidi Leister‐Tebbe, Rienk Pypstra, Annie Gardner, Wayne Wisemandle, Paula Abreu, Magdalena Harrington, Jesus Abraham Simón Campos

November 11, 2024article en

10 citations

Abstract

No abstract available for this paper.

Clinical Infectious DiseasesVol. 80(2)

University of California, Los Angeles (US), Pfizer (United States) (US), Anahuac Mayab University (MX), Kohler (United States) (US)

Pfizer

Openalex Percentile: Top 5%

Thermal Regulation in Medicine

4.22

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.